Related Experiment Video
Updated: Jul 28, 2026
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Serum and Saliva Myelin Basic Protein as Multiple Sclerosis Biomarker
Mohammad Hossein Mirzaii-Dizgah1, Mohammad Reza Mirzaii-Dizgah2, Iraj Mirzaii-Dizgah3
1Student Research Committee, School of Dentistry, AJA University of Medical Sciences, Tehran, Iran.
Introduction:
Multiple Sclerosis (MS) is presented with motor and sensory function loss. It is caused by demyelination and following axonal lesion. As Myelin Basic Protein (MBP) is one of the key elements of the myelin cover, we examined the level of MBP in serum, stimulated, and unstimulated saliva as a suitable biomarker for detecting MS.
Methods:
A case-control study was performed in 29 healthy women and 32 definitive relapsing-remitting MS patients hospitalized in Imam Reza hospital, Tehran, Iran. MBP level was assayed in serum and stimulated and unstimulated whole saliva.
Results:
MBP was expressed at a lower level in serum and stimulated saliva of MS patients compared to the control group. The serum MBP level had a considerable correlation with its stimulated saliva level. The receiver operating characteristic analysis showed significant diagnostic ability for MBP to discriminate MS patients with serum and stimulated saliva from controls.
Conclusion:
Serum and saliva level of MBP is lower in MS, so it may be considered a potential biomarker in MS.
More Related Videos
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
